The topical beta-blocker timolol can be an effective first-line treatment for controlling symptoms of ulcerated IHs; however, its use should be carefully monitored.
![](https://www.enttoday.org/wp-content/uploads/2016/09/ENT_0916_pg6a-150x150.png)
Can Topical Beta-Blockers Reduce the Size of Superficial Infantile Hemangiomas of the Head and Neck?
Topical beta-blocker therapy is a safe treatment for patients that meet a certain criteria